SunRock’s communication has been selected for oral presentation at the 20th Congress of ECCO, February 19-22, 2025, Berlin, Germany.

DOP065 SRB1: a Best-in-Class CCR9 depleting antibody that restores immune homeostasis in IBD patients

https://academic.oup.com/ecco-jcc/article/19/Supplement_1/i209/7966915